Initial data has shown immunity triggered by the two mRNA vaccines -- Pfizer-BioNTech and Moderna -- lasts for at least six months
Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.
'Today, our vast green pastures where local herders used to take their cattle to graze have been taken over by the Chinese.' 'The people in the Galwan Valley have lost their lands where their cattle used to graze.'